Vivo Bio Tech Ltd

NSE: VIVOBIOT · BSE: 511509 · Pharmaceuticals & Biotechnology · 31 announcements

Share price: ₹14.11
Market cap: ₹22.76 Cr
Revenue (annual): ₹53.33 Cr
Net profit (annual): ₹-1.71 Cr
P/E (TTM): -8.7×Sector 43.8×
Promoter holding: 22.51%-8.11% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 7 Financial Results 5 Board Meeting Date 4 Annual General Meeting 4 Management Change 3 Promoter Selling 2 Capital Structure Change 2 Promoter Selling (Off-Market) 1 Board Meeting Outcome 1 Annual Report 1 Adverse Business Impact 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

30 Sep 2026 19:05 IST BSE

Management Change

Vivo Bio Tech Management Change

Vivo Bio Tech Limited announced the re-appointment of Sri Kalyan Kompella and Sankaranarayanan Alangudi as Executive Directors, effective November 2026 and January 2027 respectively.

Open announcement → Read the filing ↗

22 Aug 2026 19:44 IST BSE

Management Change

Vivo Bio Tech Management Change

Vivo Bio Tech Limited announced the re-appointment of Mr. Sri Kalyan Kompella and Mr. Sankaranarayanan Alangudi as Executive Directors of the company.

Open announcement → Read the filing ↗

24 Jun 2026 16:34 IST BSE

Management Change

Vivo Bio Tech Management Change

Vivo Bio Tech announced the resignation of Mr. A V Kiran as Company Secretary. Mr. Bhavish Vijayvargiya was appointed to the role effective June 24, 2026.

Open announcement → Read the filing ↗